It was reported yesterday that Galderma, a company focused on skin health medical treatments, has named Chris Chapman as its new Vice President and General Manager of Prescription Business in the United States, effective 1 September 2017.

Chapman earlier served as Vice President of Strategic Access for Galderma's Prescription Business Unit. He joined Galderma in 2015, initially responsible for commercial payer account management and contracting, trade account management and branded consumer rebate programmes.

Chapman will now oversee Galderma's portfolio of products that treat acne, psoriasis, eczema and rosacea. He will also oversee Galderma CareConnect, a patient savings card programme that offers discounts to patients on its products.